News
  • Interview with CEO of Ra Medical Systems

    To Access the article on MedGadget website click here. written by: Alice Ferng More than 200 million people worldwide, including approximately 8.5 million Americans, suffer from Peripheral Artery Disease (PAD). In the U.S. and Europe, PAD is responsible for around 240,000 amputations every year. Nearly a quarter of patients die within 30 Read More...

     

  • Ra Medical Systems Receives FDA Clearance for Laser Ablation

    To access the article on Photonics Media's website click here. CARLSBAD, Calif. — In an effort to battle Peripheral Artery Disease (PAD), the leading cause of limb amputations, the FDA has granted market clearance to laser developer Ra Medical Systems Inc., makers of excimer lasers and catheters for cardiovascular and Read More...

     

  • Ra Medical CEO Irwin Aims for Feb 2018 IPO

    To access the article on MassDevices' website click here.  In May, Ra Medical received a nod from the FDA for its DABRA arteriosclerosis laser, clearing it for use in the US. It was a decision the company had been waiting on for approximately 3 years, CEO Dean Irwin told MassDevice.com in an interview, and signaled a Read More...

     

  • DABRA Laser Ablates Blocked Arteries

    To access the article on MedGadget's website click here. Ra Medical, a company out of Carlsbad, California, received FDA clearance and is reporting the first commercial use of its DABRA laser-based arterial blockage ablation system. Unlike most other intravascular tools used for removing arterial plaque that rely on mechanical methods, Read More...

     

  • FDA Clears Ra Medical’s DABRA Areteriosclerosis Laser

    To access the article on MassDevice's website click here. BY FINK DENSFORD Medical excimer laser developer Ra Medical said it won FDA 510(k) clearance for its DABRA system designed to treat patients with peripheral artery disease. The Carlsbad, Calif.-based company said that the system is designed to destroy arteriosclerotic blockages through the use Read More...

     

  • Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment

    To access the article on the FDANEWS' website click here. The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment. The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower Read More...

     

  • Ra Medical Bags FDA Nod for PAD Device

    To access the article on FierceBiotech's website click here. by Amirah Al Idrus The FDA cleared Ra Medical Systems’ catheter-and-laser atherectomy system for the treatment of peripheral artery disease (PAD), which commonly causes pain in the legs and can require amputation if left untreated. PAD refers to narrowed blood vessels that restrict blood Read More...

     

  • San Diego Business Journal: Ra Medical Aims to Be a Leading Light in Clearing Arteries

    To access the story on the San Diego Business Journal Click here By: Brittany Meiling Ra Medical’s DABRA system, which recently received FDA OK for sales, uses liquid encased in a tube, rather than chunks of glass or woven fiber optic bundles, to deliver its laser. Photo courtesy of Ra Medical Systems Inc. Read More...

     

  • Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

    To access the article on the New York Times' Business Day Markets section click here. Prominent Additions Represent Full Spectrum of Medical and Investing Leadership CARLSBAD, Calif.--(BUSINESS WIRE)--Jul. 11, 2017-- Following the €1.9 billion ($2.16 billion) purchase of The Spectranetics Corporation (NASDAQ:SPNC) by Royal Philips(NYSE:PHG), Ra Medical Systems, makers of cardiovascular and dermatology catheters Read More...

     

Social Media Blog
2017Previous Years